Advertisement

Topics

Did Pfizer Blink, And What Will Pharma Do Now?

06:39 EDT 13 Jul 2018 | Forbes

Pfizer confirmed that time has run out for raising prices without blow-back. The renewed attention to drug price hikes means business as usual has ended and two questions loom large for Pharma. Is talk of regulation of drug prices next and who will next gain attention because of Pfizer and why?

Original Article: Did Pfizer Blink, And What Will Pharma Do Now?

NEXT ARTICLE

More From BioPortfolio on "Did Pfizer Blink, And What Will Pharma Do Now?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...